Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Wappler

Showing results (71-80 of 163) with videos related to

Pageof 17
Sort By:
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|June 9, 1998
[Evaluation of malignant hyperthermia episodes with the Clinical Grading Scale]V von Richthofen, F Wappler, J Scholz, et al.
Der Anaesthesist|May 12, 2012
[Preoperative risk evaluation of adult patients for elective, noncardiac surgical interventions. Results of an on-line survey on the status in Germany]A B Böhmer, J Defosse, G Geldner, et al.
British Journal of Anaesthesia|May 17, 2017
Drug safety in paediatric anaesthesiaJ Kaufmann, A R Wolf, K Becke, et al.
Anesthesia and Analgesia|June 1, 1996
In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal musclesF Wappler, N Roewer, A Köchling, et al.
British Journal of Anaesthesia|May 1, 1997
Inositol 1,4,5-trisphosphate in blood and skeletal muscle in human malignant hyperthermiaF Wappler, J Scholz, A Köchling, et al.
European Journal of Anaesthesiology|August 6, 2000
Inositol 1,4,5-trisphosphate synthesis in mononuclear white blood cells of malignant hyperthermia-susceptible and normal human beings, following in vitro exposure to halothane, caffeine and ryanodineU Martens, T Krause, J Scholz, et al.
Intensive Care Medicine|August 1, 1996
Fulminant malignant hyperthermia associated with ketoacidotic diabetic comaF Wappler, N Roewer, A Köchling, et al.
British Journal of Anaesthesia|March 15, 2013
Non-invasive continuous arterial pressure monitoring with Nexfin does not sufficiently replace invasive measurements in critically ill patientsA Hohn, J M Defosse, S Becker, et al.
Der Anaesthesist|June 22, 2001
[Malignant neuroleptic syndrome after haloperidol administration]M U Gerbershagen, W D Ito, F Wappler, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|April 8, 1998
[Level concept of analgesic dosing in intensive care medicine with sufentanil]F Wappler, J Scholz, A Prause, et al.
Pageof 17

Showing results (71-80 of 163) with videos related to

Sort By:
Pageof 17
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|June 9, 1998
[Evaluation of malignant hyperthermia episodes with the Clinical Grading Scale]V von Richthofen, F Wappler, J Scholz, et al.
Der Anaesthesist|May 12, 2012
[Preoperative risk evaluation of adult patients for elective, noncardiac surgical interventions. Results of an on-line survey on the status in Germany]A B Böhmer, J Defosse, G Geldner, et al.
British Journal of Anaesthesia|May 17, 2017
Drug safety in paediatric anaesthesiaJ Kaufmann, A R Wolf, K Becke, et al.
Anesthesia and Analgesia|June 1, 1996
In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal musclesF Wappler, N Roewer, A Köchling, et al.
British Journal of Anaesthesia|May 1, 1997
Inositol 1,4,5-trisphosphate in blood and skeletal muscle in human malignant hyperthermiaF Wappler, J Scholz, A Köchling, et al.
European Journal of Anaesthesiology|August 6, 2000
Inositol 1,4,5-trisphosphate synthesis in mononuclear white blood cells of malignant hyperthermia-susceptible and normal human beings, following in vitro exposure to halothane, caffeine and ryanodineU Martens, T Krause, J Scholz, et al.
Intensive Care Medicine|August 1, 1996
Fulminant malignant hyperthermia associated with ketoacidotic diabetic comaF Wappler, N Roewer, A Köchling, et al.
British Journal of Anaesthesia|March 15, 2013
Non-invasive continuous arterial pressure monitoring with Nexfin does not sufficiently replace invasive measurements in critically ill patientsA Hohn, J M Defosse, S Becker, et al.
Der Anaesthesist|June 22, 2001
[Malignant neuroleptic syndrome after haloperidol administration]M U Gerbershagen, W D Ito, F Wappler, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|April 8, 1998
[Level concept of analgesic dosing in intensive care medicine with sufentanil]F Wappler, J Scholz, A Prause, et al.
Pageof 17